EMA (EU)
GUIDANCE FINAL
Guideline on data requirements to support in-use stability claims for veterinary vaccines - Revision 1
Published: 7/24/2026Detected: 7/24/2026
Summary preview
Clarifies the data package needed to support in-use stability claims for veterinary vaccines, helping applicants align stability evidence with how products are actually stored and used after container opening or first…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
safety
labeling
#veterinary vaccines
#in-use stability
#stability studies
#shelf-life
#container-closure system
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system10/12/2026
- First European Medicines Agency (EMA) - International Society for Cell and Gene Therapy (ISCT) bilateral meeting10/12/2026
- Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 202610/8/2026
- PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 202610/8/2026
- SPOR and XEVMPD status update webinar - Q4 202610/7/2026